Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Earnings, Drug Deals Drive U.S. Markets

Published 04/22/2014, 04:16 PM
Updated 07/09/2023, 06:31 AM

Stocks extended their rally to a sixth day, drifting off their best levels in afternoon trade and led by broad gains for healthcare stocks following a $28.5 million asset swap between Novartis AG (NYSE:NVS), GlaxoSmithKline Plc. (NYSE:GSK), and Eli Lilly and Co. (NYSE:LLY). Market-friendly data along with strong earnings by Netflix (NASDAQ:NFLX) and Comcast (NASDAQ:CMCSA) and a positive outlook by McDonald's (NYSE:MCD) also kept the major market gauges on positive ground.

Big Deals
Deal-making among pharmaceutical companies helped propel healthcare stocks to a market-leading position Tuesday. In pair of transactions, NVS will sell most of its animal-health division to LLY for $5.4 billion while also selling most of its vaccines division to GSK for $7.1 billion. In return, NVS will pay up to $16 billion to acquire new cancer drugs from the other two firms.

Also Tuesday, AstraZeneca PLC. (AZN) slipped about 3% -- giving back a portion of Monday's 8% advance -- after reportedly rebuffing a $100 billion takeover offer by Pfizer (NYSE:PFE). Neither company has commented on the market rumors.

Tepid Data
Eearlier Tuesday, the Commerce Department reported existing home sales fell 0.2% in March to a seasonally-adjusted annual pace of 4.59 million, still better than the 0.8% drop the Street was expecting. Also, the Richmond Fed manufacturing index Tuesday reversed a 7.0 decline last month to record a 7.0-point rise in April, beating expectations for the index to rise to a 0.0 reading this month.

Commodities were mostly higher although crude oil for May delivery settled $2.24 lower at $102.13 per barrel in moderate profit-taking after the front-month contract hit a year-to-date high yesterday. May natural gas was up 4 cents to finish at $4.74 per 1 million BTU. June gold fell $7.10 to $1281.10 per ounce while May silver added 2 cents to $19.36 per ounce. May copper settled a penny higher at $3.05 per pound.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Here's Where The U.S. Markets Stood At Day's End

  • Dow Jones Industrial Average up 65.12 (+0.40%) to 16,514.37
  • S&P 500 up 7.66 (+0.41%) to 1,879.55
  • Nasdaq Composite Index up 39.91 (+0.97%) to 4,161.46

GLOBAL SENTIMENT

  • Hang Seng Index down 0.13%
  • Shanghai China Composite Index up 0.34%
  • FTSE 100 Index up 0.85%

UPSIDE MOVERS

  • (+) RCII, Posts Q1 EPS of $0.57 per share, ex items, beating the Capital IQ consensus by $0.02 per share. Revenue rose 1.7% year over year to $833 million, narrowly trailing the Street view by $7.77 million.
  • (+) CNC, Per-share Q1 net income of $0.57 bests Capital IQ consensus by $0.12 per share. Revenue rose 31.9% year over year to $3.35 billion, exceeding expectations by around $100 million.
  • (+) NFLX, Q1 adjusted earnings of $0.86 per share top estimates by $0.04. Revenue climbs 24.0% year over year to $1.27, matching consensus. Projected Q2 EPs of $1.12, ex items, beats by $0.13 per share.

DOWNSIDE MOVERS

  • (-) MDSO, Q1 earnings of $0.11 per share miss the Capital IQ consensus for Q1 by $0.05 per share. Revenue rose 21% over year-ago levels to $76.6 million, trailing the Street view by $2.95 million.
  • (-) LXK, Forecasts 2% to 4% decline in revenue during the current quarter, resulting in adjusted earnings of $0.85 per share to $0.95 per share. Analysts are looking for Q2 EPS of $0.94 per share on $856.08 million in revenue.
  • (-) BEBE, Warns of a steeper Q2 net loss than previous expected after cold weather in many parts of the U.S. hampered sales. Now expects $0.29 per share loss, $0.14 wider than the analyst consensus.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

After Hours Stock News From Midnight Trader.

Copyright © 2014 MT Newswires, a Division of MidnightTrader, Inc.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.